Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Ovarian cancer is the sixth most common malignancy among women in developed countries and the fifth leading cause of cancer-related death, representing a complex disease associated with poor survival rates.24 The combination chemotherapy of Paclitaxel (PTX) and Carboplatin (CARB) is considered the first-line treatment regimen for ovarian cancer.25 Both agents play distinct roles in inhibiting the growth of ovarian cancer through different mechanisms,26 and they are known to exert a synergistic anti-tumor effect by activating separate apoptotic signaling pathways, thereby potentially reducing drug resistance.25 The gonadotoxic effects of platinum-based chemotherapeutic agents have been demonstrated in numerous studies, both histopathologically and in terms of follicular development.27-29 In the present study, CARB administration led to significant histopathological damage in ovarian tissue, including follicular degeneration, prominent stromal edema, congestion, hemorrhage, inflammation, and fibrosis, particularly in the medullary region
Research shows that SFN can restore NQO1 enzyme activity in leukemia cells carrying this polymorphism, which normally results in reduced activity ( Crucially, for the most extensively studied GST polymorphisms, the metabolic impact is profound and counterintuitive
ATP exposure stimulates glutathione efflux as a necessary switch for NLRP3 inflammasome activation
Supporting Your Internal Production While supplementation is a powerful tool, you can also support your bodys ability to create its own glutathione
Each box provides 30 servings in a delicious orange spice flavour for improved compliance
305 N-Acetylgalactosamine (GalNAc) Most approved products based on bio-conjugated delivery systems use the GalNAc-coupled delivery system developed by Alnylam Pharmaceuticals
US$ 21.55
US$ 21.75
US$ 24.72
US$ 27.69
US$ 23.27
